Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
International Journal of Oncology|August 1, 2013
Precancerous colorectal lesions (Review)Vincenza Conteduca, Domenico Sansonno, Sabino Russi, et al.
European Urology Focus|February 18, 2019
Biological Evolution of Castration-resistant Prostate CancerAlastair Davies, Vincenza Conteduca, Amina Zoubeidi, et al.
Clinical & Developmental Immunology|July 31, 2012
Hepatitis C virus infection and mixed cryoglobulinemiaGianfranco Lauletta, Sabino Russi, Vincenza Conteduca, et al.
Current Cancer Drug Targets|January 4, 2018
Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical ImplicationsKatarina Kalavska, Vincenza Conteduca, Ugo De Giorgi, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2022
Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysisGiuseppe Bronte, Vincenza Conteduca, Matteo Landriscina, et al.
British Journal of Cancer|July 13, 2023
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancerVincenza Conteduca, Nicole Brighi, Giuseppe Schepisi, et al.
Critical Reviews in Oncology/Hematology|October 25, 2012
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversyVincenza Conteduca, Giuseppe Di Lorenzo, Alfredo Tartarone, et al.
Critical Reviews in Oncology/Hematology|June 24, 2014
Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategiesVincenza Conteduca, Michele Aieta, Dino Amadori, et al.
The Journal of Infection|September 10, 2013
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agentsVincenza Conteduca, Domenico Sansonno, Sabino Russi, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented testEnrique González-Billalabeitia, Vincenza Conteduca, Daniel Wetterskog, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
International Journal of Oncology|August 1, 2013
Precancerous colorectal lesions (Review)Vincenza Conteduca, Domenico Sansonno, Sabino Russi, et al.
European Urology Focus|February 18, 2019
Biological Evolution of Castration-resistant Prostate CancerAlastair Davies, Vincenza Conteduca, Amina Zoubeidi, et al.
Clinical & Developmental Immunology|July 31, 2012
Hepatitis C virus infection and mixed cryoglobulinemiaGianfranco Lauletta, Sabino Russi, Vincenza Conteduca, et al.
Current Cancer Drug Targets|January 4, 2018
Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical ImplicationsKatarina Kalavska, Vincenza Conteduca, Ugo De Giorgi, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2022
Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysisGiuseppe Bronte, Vincenza Conteduca, Matteo Landriscina, et al.
British Journal of Cancer|July 13, 2023
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancerVincenza Conteduca, Nicole Brighi, Giuseppe Schepisi, et al.
Critical Reviews in Oncology/Hematology|October 25, 2012
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversyVincenza Conteduca, Giuseppe Di Lorenzo, Alfredo Tartarone, et al.
Critical Reviews in Oncology/Hematology|June 24, 2014
Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategiesVincenza Conteduca, Michele Aieta, Dino Amadori, et al.
The Journal of Infection|September 10, 2013
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agentsVincenza Conteduca, Domenico Sansonno, Sabino Russi, et al.
Prostate Cancer and Prostatic Diseases|November 11, 2018
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented testEnrique González-Billalabeitia, Vincenza Conteduca, Daniel Wetterskog, et al.
Pageof 16